Terms: = Brain cancer AND DDIT3, CHOP, 1649, ENSG00000175197, _C/EBP zeta_, MGC4154, GADD153, CHOP10, P35638
198 results:
1. Experience of multi-disciplinary treatment of multiple cerebellar diffuse large B-cell lymphoma: A case report.
Guo Y; Li J; Li M; Li Z; Cui Y; Li Y; Zhao R; Han Q; Yang H; Ma C
Medicine (Baltimore); 2024 Apr; 103(17):e37923. PubMed ID: 38669361
[TBL] [Abstract] [Full Text] [Related]
2. Systematic identification of a synthetic lethal interaction in brain-metastatic lung adenocarcinoma.
Moon JW; Hong BJ; Kim SK; Park MS; Lee H; Lee J; Kim MY
Cancer Lett; 2024 Apr; 588():216781. PubMed ID: 38494150
[TBL] [Abstract] [Full Text] [Related]
3. Profiling of Unfolded Protein Response Markers and Effect of IRE1α-specific Inhibitor in Pituitary Neuroendocrine Tumor.
Morita S; Uraki S; Ariyasu H; Tsuji T; Doi A; Furuta H; Yamoto T; Nakao N; Akamizu T; Matsuoka TA
Endocrinology; 2024 Feb; 165(4):. PubMed ID: 38289718
[TBL] [Abstract] [Full Text] [Related]
4. IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma.
Conconi A; Chiappella A; Ferreri AJM; Stathis A; Botto B; Sassone M; Gaidano G; Balzarotti M; Merli F; Tucci A; Vanazzi A; Tani M; Bruna R; Orsucci L; Cabras MG; Celli M; Annibali O; Liberati AM; Zanni M; Ghiggi C; Pisani F; Pinotti G; Dore F; Esposito F; Pirosa MC; Cesaretti M; Bonomini L; Vitolo U; Zucca E
Blood Adv; 2024 Mar; 8(6):1541-1549. PubMed ID: 38181782
[TBL] [Abstract] [Full Text] [Related]
5. Myxoid liposarcoma with nuclear pleomorphism: a clinicopathological and molecular study.
Kojima N; Kubo T; Mori T; Satomi K; Matsushita Y; Iwata S; Yatabe Y; Ichimura K; Kawai A; Ichikawa H; Yoshida A
Virchows Arch; 2024 Jan; 484(1):71-81. PubMed ID: 37704823
[TBL] [Abstract] [Full Text] [Related]
6. Single-cell RNA sequencing identifies macrophage signatures correlated with clinical features and tumour microenvironment in meningiomas.
Zhang X
IET Syst Biol; 2023 Oct; 17(5):259-270. PubMed ID: 37515398
[TBL] [Abstract] [Full Text] [Related]
7. Central nervous system prophylaxis in diffuse large B-cell lymphoma: What does the evidence tell us?
Lantz J; Portell CA; Ayers EC
Blood Rev; 2023 Sep; 61():101101. PubMed ID: 37258362
[TBL] [Abstract] [Full Text] [Related]
8. Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis.
Thieblemont C; Altmann B; Frontzek F; Renaud L; Chartier L; Ketterer N; Récher C; Poeschel V; Fitoussi O; Held G; Casasnovas O; Haioun C; Morschhauser F; Glass B; Mounier N; Tilly H; Rosenwald A; Ott G; Lenz G; Molina T; Ziepert M; Schmitz N
Blood Adv; 2023 Aug; 7(15):3968-3977. PubMed ID: 36716220
[TBL] [Abstract] [Full Text] [Related]
9. Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma Transforming into Diffuse Large B-Cell Lymphoma in a Young Adult Patient with Neurofibromatosis Type 1: A Case Report.
Kosako H; Yamashita Y; Tanaka K; Mishima H; Iwamoto R; Kinoshita A; Murata SI; Ohshima K; Yoshiura KI; Sonoki T; Tamura S
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557032
[No Abstract] [Full Text] [Related]
10. Diterpenoid DGA induces apoptosis via endoplasmic reticulum stress caused by changes in glycosphingolipid composition and inhibition of STAT3 in glioma cells.
Kong T; He Z; Wang S; Jiang C; Zhu F; Gao J; Li L; Wang Y; Xie Q; Li Y
Biochem Pharmacol; 2022 Nov; 205():115254. PubMed ID: 36210604
[TBL] [Abstract] [Full Text] [Related]
11. NRF2 mediates melanoma addiction to GCDH by modulating apoptotic signalling.
Verma S; Crawford D; Khateb A; Feng Y; Sergienko E; Pathria G; Ma CT; Olson SH; Scott D; Murad R; Ruppin E; Jackson M; Ronai ZA
Nat Cell Biol; 2022 Sep; 24(9):1422-1432. PubMed ID: 36050469
[TBL] [Abstract] [Full Text] [Related]
12. GSH-AuNP anti-oxidative stress, ER stress and mitochondrial dysfunction in amyloid-beta peptide-treated human neural stem cells.
Chiang MC; Nicol CJB
Free Radic Biol Med; 2022 Jul; 187():185-201. PubMed ID: 35660451
[TBL] [Abstract] [Full Text] [Related]
13. Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumors.
Parkhurst A; Wang SZ; Findlay TR; Malebranche KJ; Odabas A; Alt J; Maxwell MJ; Kaur H; Peer CJ; Figg WD; Warren KE; Slusher BS; Eberhart CG; Raabe EH; Rubens JA
Cell Death Dis; 2022 Apr; 13(4):410. PubMed ID: 35484114
[TBL] [Abstract] [Full Text] [Related]
14. Tetralol derivative NNC-55-0396 induces glioblastoma cell death by activating IRE1α, JNK1 and calcium signaling.
Visa A; Alza L; Cantí C; Herreros J
Biomed Pharmacother; 2022 May; 149():112881. PubMed ID: 35367758
[TBL] [Abstract] [Full Text] [Related]
15. A Preliminary Study of the Effect of Quercetin on Cytotoxicity, Apoptosis, and Stress Responses in Glioblastoma Cell Lines.
Kusaczuk M; Krętowski R; Naumowicz M; Stypułkowska A; Cechowska-Pasko M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163269
[TBL] [Abstract] [Full Text] [Related]
16. Nitroglycerin Plus Whole Intracranial Radiation Therapy for brain Metastases in Patients With Non-Small Cell Lung cancer: A Randomized, Open-Label, Phase 2 Clinical Trial.
Arrieta O; Hernández-Pedro N; Maldonado F; Ramos-Ramírez M; Yamamoto-Ramos M; López-Macías D; Lozano F; Zatarain-Barrón ZL; Turcott JG; Barrios-Bernal P; Orozco-Morales M; Flores-Estrada D; Cardona AF; Rolfo C; Cacho-Díaz B
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):592-607. PubMed ID: 35157994
[TBL] [Abstract] [Full Text] [Related]
17. Novel Dual PI3K/mTOR Inhibitor, Apitolisib (GDC-0980), Inhibits Growth and Induces Apoptosis in Human Glioblastoma Cells.
Omeljaniuk WJ; Krętowski R; Ratajczak-Wrona W; Jabłońska E; Cechowska-Pasko M
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768941
[TBL] [Abstract] [Full Text] [Related]
18. [Clinicopathological features of intravascular peripheral T-cell lymphoma].
Guan X; Yang YC; Qi Y; Gong WC; Xu XY; Wang YL; Guo YH; Luo Y; Sun L; Fu K; Meng B
Zhonghua Xue Ye Xue Za Zhi; 2021 Jul; 42(7):583-590. PubMed ID: 34455746
[No Abstract] [Full Text] [Related]
19. Informatics Methods and Infrastructure Needed to Study Factors Associated with High Incidence of Pediatric brain and Central Nervous System Tumors in Kentucky.
Durbin EB; Christian WJ; Hands I; Koptyra MP; Jong JC; Badgett TC
J Registry Manag; 2020; 47(3):127-134. PubMed ID: 34128919
[TBL] [Abstract] [Full Text] [Related]
20. R-chop intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement.
Steinhardt MJ; Krummenast FC; Rosenwald A; Gerhard-Hartmann E; Heidemeier A; Einsele H; Topp MS; Duell J
J Cancer Res Clin Oncol; 2022 Jan; 148(1):205-214. PubMed ID: 34085097
[TBL] [Abstract] [Full Text] [Related]
[Next]
